Table 2.
Number of Individuals (%) | |
---|---|
Of those who were assessed for treatment (n = 109) | |
⮚Initiated treatment as of 3 November 2022 | 100 (91.7%) |
⮚Due to commence treatment | 3 (2.8%) |
⮚Treatment deferred | 1 (0.9%) |
⮚Lost to follow up | 5 (4.6%) |
Of those who initiated treatment (n = 100) | |
⮚Completed treatment with SVR * as of 3 November 2022 | 68 (68%) |
⮚Completed treatment with no follow up SVR | 30 (30%) |
⮚Defaulted treatment | 2 (2%) |
* Sustained Virologic Response (SVR).